|
|
|
| Progress in pharmacological studies on rutaecarpine |
| YUAN Zhijian HE Wenjuan HU Jing▲ |
| Nursing College, Wuxi Higher Health Vocational Technology School, Jiangsu Province, Wuxi 214028, China |
|
|
|
Abstract Rutaecarpine is one of the main active components of Chinese medicine Evodia rutaecarpa. It has extensive physiological and pharmacological effect, including positive inotropic and cardioprotective effect, and can vasorelaxant and reduce blood pressure. It can protect gastric mucosa and has therapeutic effect on ulcerative colitis. In addition, rutaecarpine also has antidepressant, anti-obesity, anti-tumor effect, analgesic and anti-inflammatory effects, etc. With further study of rutaecarpine by domestic and foreign scholars in recent years, this article reviews the research progress of its pharmacological effect, and aims at providing preference for reasonable exploitation in future.
|
|
|
|
|
|
[1] Son J，Chang HW，Jahng Y. ChemInform Abstract：Progress in Studies on Rutaecarpine. Ⅱ.-Synthesis and Structure-Biological Activity Relationships [J]. Molecules，2015，20（6）：108 00-108 21.
[2] 段徐，凌峰.吴茱萸次碱的药理作用[J].中华中医药学刊，2007，25（9）：1857-1859.
[3] Jia SJ，Hu CP. Pharmacological effects of rutaecarpine as a cardiovascular protective agent [J]. Molecules，2010，15（3）：1873-1881.
[4] Hu CP，Li NS，Xiao L，et al. Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats [J]. Regul Pept，2003，114（1）：45-49.
[5] Yi HH，Rang WQ，Deng PY，et al. Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP [J]. Planta Med，2004，70（12）：1135.
[6] Wang C，Hao Z，Zhou J，et al. Rutaecarpine alleviates renal ischemia reperfusion injury in rats by suppressing the JNK/p38 MAPK signaling pathway and interfering with the oxidative stress response [J]. Mol Med Rep，2017，16（1）：922.
[7] Li WQ，Li XH，Du J，et al. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats [J]. Naunyn Schmiedebergs Arch Pharmacol，2016，389（7）：757-767.
[8] Li XW，Hu CP，Li YJ，et al. Inhibitory effect of l-mimosine on bleomycin-induced pulmonary fibrosis in rats：Role of eIF3a and p27 [J]. Int Immunopharmacol，2015，27（1）：53-64.
[9] 张婧怡，林淑娴，李利生，等.吴茱萸次碱对腹主动脉缩窄大鼠左室肥厚的抑制作用[J].医药导报，2018，37（2）：152-156.
[10] Wang GJ，Wu XC，Chen CF，et al. Vasorelaxing action of rutaecarpine：effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells [J]. J Pharmacol Exp Ther，1999，289（3）：1237-1244.
[11] Hu CP，Xiao L，Leng HW，et al. The Depressor and Vasodilator Effects of Rutaecarpine are Mediated by Calcitonin Gene-Related Peptide [J]. Planta Med，2003，69（2）：125-129.
[12] 张宇霞，黎明，张元贵.吴茱萸穴位贴敷治疗冠心病低心率变异性的临床研究[J].中国医药导报，2016，13（19）：88-91.
[13] Yan L，Li QF，Rong YT，et al. The protective effects of rutaecarpine on acute pancreatitis [J]. Oncol Lett，2018， 15（3）：3121-3126.
[14] 李艳菊，张锋，龚其海，等.吴茱萸次碱抑制血管紧张素Ⅱ诱导的大鼠血管平滑肌细胞增殖[J].中国结合医学杂志：英文版，2014，20（9）：682-687.
[15] Luo XJ，Liu B，Dai Z，et al. Stimulation of calcitonin gene-related peptide release through targeting capsaicin receptor：a potential strategy for gastric mucosal protection [J]. Dig Dis Sci，2013，58（2）：320-325.
[16] Feng G，Xu X，Wang Q，et al. The protective effects of calcitonin gene-related peptide on gastric mucosa injury after cerebral ischemia reperfusion in rats [J]. Regul Pept，2011，33（1）：84-89.
[17] Liu YZ，Zhou Y，Li D，et al. Reduction of asymmetric dimethylarginine in the protective effects of rutaecarpine on gastric mucosal injury [J]. Can J Physiol Pharmacol，2008，86（10）：675.
[18] 刘保林，吴巍巍，靳长峰，等.吴茱萸次碱对小鼠溃疡性肠炎的治疗作用[J].中国临床药理学与治疗学，2004，9（11）：1273-1277.
[19] 罗丹妮，李富军，邹益友.吴茱萸次碱对葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠的治疗作用[J].中华医学杂志，2018，98（7）：533-538.
[20] Wang QS，Ding SL，Mao HP，et al. Antidepressant-like effect of ethanol extract from Zuojin Pill，containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae，is explained by modulating the monoaminergic neurotransmitter system in mice [J]. J Ethnopharmacol，2013， 148（2）：603-609.
[21] 郭惠，王珍珍，杨琦，等.吴茱萸次碱对三种肿瘤细胞体外增殖抑制作用的研究[J].中药药理与临床，2015，31（5）：44-47.
[22] Rannug U，Agurell E，Rannug A，et al. Certain tryptophan photoproducts are inhibitors of cytochrome P450-dependent mutagenicity [J]. Environ Mol Mutagen，1992， 20（4）：289-296.
[23] Don MJ，Lewis DFV，Wang SY，et al. Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1，CYP1A2，and CYP1B1 [J]. Bioorg Med Chem Lett，2003，13（15）：2535-2538.
[24] Iwata H，Tezuka Y，Kadota S，et al. Mechanism-Based Inactivation of Human Liver Microsomal CYP3A4 by Rutaecarpine and Limonin from Evodia Fruit Extract [J]. Drug Metab Pharmacokinet，2005，20（1）：34-45.
[25] Nie XQ，Chen HH，Zhang JY，et al. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed，streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways [J]. Acta Pharmacologica Sinica，2016，37（4）：483.
[26] Moon TC，Murakami M，Kudo I，et al. A new class of COX-2 inhibitor，rutaecarpine from Evodia rutaecarpa [J]. Inflamm Res，1999，48（12）：621-625.
[27] 林丽君，周春姣，何军明，等.吴茱萸+芒硝外用辅助干预用于重症胰腺炎的疗效研究[J].中国医药导报，2017， 14（33）：147-150.
[28] Yarosh DB，Galvin JW，Nay SL，et al. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa，extract from traditional Chinese medicine [J]. J Dermatol Sci，2006，42（1）：13-21.
[29] Ko HC，Wang YH，Liou KT，et al. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells [J]. Eur J Pharmacol，2007，555（2）：211-217.
[30] Cai QY，Li WR，Wei JJ，et al. Antinociceptive Activity of Aqueous and Alcohol Extract of Evodia Rutaecarpa [J]. Indian J Pharm Sci，2014，76（3）：235-239.
[31] 杨建文，聂绪强，史海霞，等.吴茱萸次碱对胰岛素抵抗骨骼肌细胞炎症因子表达的影响[J].中国中药杂志，2014，39（15）：2930-2935.
[32] 刘斌，李静，胡惠清，等.吴茱萸次碱软膏对小鼠特应性皮炎的保护作用及相关机制研究[J].实用皮肤病学杂志，2016，9（3）：165-167. |
|
|
|
